Differences in P50 and prepulse inhibition of the startle reflex between male smokers and non-smokers with first episode schizophrenia without medical treatment

Chinese Medical Journal

Volumn 127, Issue 9, 2014, Pages 1651-1655

  Song, Lisheng ^a   Chen, Xingshi ^a   Chen, Meijuan ^a   Tang, Yunxiang ^b   Wang, Jijun ^a   Zhang, Mingdao ^a   Lou, Feiying ^a   Liang, Jianhua ^a   Chen, Chong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

P50; Prepulse inhibition of the startle reflex; Schizophrenia; Smoking

Indexed keywords

ADULT; AMPLITUDE MODULATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; EVENT RELATED POTENTIAL; HUMAN; LATENT PERIOD; MALE; NERVE STIMULATION; NERVOUS SYSTEM FUNCTION; P50; POSITIVE AND NEGATIVE SYNDROME SCALE; PREPULSE INHIBITION; SCHIZOPHRENIA; SENSORY GATING; SMOKING; STARTLE REFLEX; ADVERSE EFFECTS; CASE CONTROL STUDY; DRUG EFFECTS; EVOKED RESPONSE; PATHOPHYSIOLOGY; PHYSIOLOGY; YOUNG ADULT;

ADULT; CASE-CONTROL STUDIES; EVOKED POTENTIALS; HUMANS; MALE; REFLEX, STARTLE; SCHIZOPHRENIA; SMOKING; YOUNG ADULT;

EID: 84899711904     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20133306     Document Type: Article

References (17)

1. Forcelli PA, West EA, Murnen AT, Malkova L. Ventral pallidum mediates amygdala-evoked deficits in prepulse inhibition. Behav Neurosci 2012; 162: 290-300.
2. Hasenkamp W, Norrholm SD, Green A, Lewison B, Boshoven W, Keyes M, et al. Differences in startle reflex and prepulse inhibition in European-Americans and African-Americans. Psychophysiology 2008; 45: 876-882.
3. Braff DL, Light GA. The use of neurophysiological endophenotypes to understand the genetic basis of schizophrenia. Dialogues Clin Neurosci 2005; 7: 125-135.
4. Schwarzkopf SB, Lambeti JS, Smith DA. Concurrent assessment of acoustic startle and auditory P50 evoked potential measures of sensory inhibition. Biol Psychiatry 1993; 33: 815-828.
5. Oranje B, van Berckel BN, Kemner C, van Ree JM, Kahn RS, Verbaten MN. P50 suppression and prepulse inhibition of the startle reflex in humans: a correlational study. Biol Psychiatry 1999; 45: 883-890.
6. Oranje B, Wienberg M, Glenthoj BY. A single high dose of escitalopram disrupts sensory gating and habituation, but not sensorimotor gating in healthy volunteers. Psychiatry Res 2011; 186: 431-436.
7. Kumari V, Postma P. Nicotine use in schizophrenia: the selfmedication hypotheses. Neurosci Biobehav Rev 2005; 29: 1021-1034.
8. Adler LE, Hoffer LD, Wiser A, Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry 1993; 250: 1856-1861.
9. Crawford HJ, Mc Clain-Furmanski D, Castagnoli N Jr, Castagnoli K. Enhancement of auditory sensory gating and stimulus-bound gamma band (40Hz) oscillations in heavy tobacco smokers. Neurosci Lett 2002; 317: 151-155.
10. Croft TJ, Dimoska A, Gonsalvez CJ, Clarke AR. Suppression of P50 evoked potential component, schizotypal beliefs and smoking. Psychiatry Res 2004; 128: 53-62.
11. Chen XS, Li C, Smith RC, Xiao ZP, Wang JJ. Differential sensory gating functions between smokers and non-smokers among drug-naive first episode schizophrenic patients. Psychiatry Res 2011; 188: 327-333.
12. Ji B, Mei W, Zhang JX, Jing J, Wu Q, Zhuo Y, et al. Abnormal auditory sensory gating-out in first-episode and never-medicated paranoid schizophrenia patients: an fMRI study. Exp Brain Res 2013; 229: 139-147.
13. Martin LF, Leonard S, Hall MH, Tregellas JR, Freedman R, Olincy A. Sensory gating and alpha-7 nicotinic receptor gene allelic variants in schizoaffective disorder, bipolar type. Am J Med Genet B Neuropsychiatr Genet 2007; 144B: 611-614.
14. Keri S, Beniczky S, Kelemen O. Suppression of the P50 evoked response and neuregulin 1-induced AKT phosphorylatin in first-episode schizophrenia. Am J Psychiatry 2010; 157: 440-450.
15. Winterer G, Weinberger DR. Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci 2004: 27: 683-690.
16. Fowler JS, Logan J, Wang GJ, Volkow ND. Monoamine oxidase and cigarette smoking. Neurotoxicology 2003; 24: 75-82.
17. Tregellas JR, Shatti S, Tanabe JL, Martin LF, Gibson L, Wylie K, et al. Gray matter volume differences and the effects of smoking on gray matter in schizophrenia. Schizophr Res 2007; 97: 242-249.